Compare DFIN & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DFIN | AORT |
|---|---|---|
| Founded | 1983 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.1B |
| IPO Year | N/A | 1993 |
| Metric | DFIN | AORT |
|---|---|---|
| Price | $46.01 | $44.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $63.50 | $49.36 |
| AVG Volume (30 Days) | 256.3K | ★ 346.5K |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $750,800,000.00 | $422,646,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | $4.20 | $10.96 |
| P/E Ratio | $40.93 | ★ N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $37.80 | $21.97 |
| 52 Week High | $69.93 | $48.04 |
| Indicator | DFIN | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 51.19 |
| Support Level | $45.00 | $42.68 |
| Resistance Level | $46.80 | $46.02 |
| Average True Range (ATR) | 1.30 | 1.35 |
| MACD | -0.03 | -0.18 |
| Stochastic Oscillator | 20.66 | 53.39 |
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.